Global Gastroretentive Drug Delivery Systems Market, By System Type (High Density System, Expandable Drug Delivery System, Bioadhesive Drug Delivery Systems, Floating Drug Delivery Systems, Others), Dosage Form (Tablets, Liquid, Microspheres, Capsule, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights: Global Gastroretentive Drug Delivery Systems Market
The gastroretentive drug delivery systems market is expected to witness market growth at a rate of 6.40% in the forecast period of 2021 to 2028. Data Bridge Market Research report on gastroretentive drug delivery systems market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rapid advancements in the healthcare sector globally is escalating the growth of gastroretentive drug delivery systems market.
Gastroretentive drug delivery is a system to deal with delay gastric home time by focusing in the vicinity explicit drugs discharge in the upper gastrointestinal lot (GIT) for foundational or neighborhood impacts. It is achieved by holding measurement structure into stomach and by delivering the drugs in controlled way. The dosage of drug is categorized into capsule, microspheres, liquid, tablets, and others.
The increase in the burden of disease across the globe acts as one of the major factors driving the growth of gastroretentive drug delivery systems market. The rise in the initiatives taken by the pharmaceuticals such as investments in the developing gastroretentive drug delivery systems (DDSs), and rise in demand for the drugs because of improved bioavailability as well as reduction in the essential required dosage accelerate the market growth. The well-established efficacy of gastroretentive drug delivery systems in addressing numerous gastric disorder including peptic ulcer and gastric ulcer, and increase in the prevalence of H. Pylori infection that can cause gastritis, and gastric cancer, among others further influence the market. Additionally, surge in infrastructure development in the health care sector, rise in government initiatives, increase in number of hospitals and ambulatory centers and favorable policies positively affects the gastroretentive drug delivery systems market. Furthermore, technological and scientific advancements in research and development activities of rate-controlled oral drug delivery methods extend profitable opportunity to the market players in the forecast period of 2021 to 2028.
- On the other hand, increased cost per dosage unit and difficulty in delivering high molecular weight compound are expected to obstruct the market growth. The reluctance in using the system and lack of awareness are projected to challenge the gastroretentive drug delivery systems market in the forecast period of 2021-2028.
This gastroretentive drug delivery systems market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on gastroretentive drug delivery systems market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Gastroretentive Drug Delivery Systems Market Scope and Market Size
The gastroretentive drug delivery systems market is segmented on the basis of system type, dosage form and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of system type, the gastroretentive drug delivery systems market is segmented into high density system, expandable drug delivery system, bioadhesive drug delivery systems, floating drug delivery systems and others.
- On the basis of dosage form, the gastroretentive drug delivery systems market is segmented into tablets, liquid, microspheres, capsule and others.
- On the basis of distribution channel, the gastroretentive drug delivery systems market is segmented into hospital pharmacies, retail pharmacies and online pharmacies.
Gastroretentive Drug Delivery Systems Market Country Level Analysis
The gastroretentive drug delivery systems market is analyzed and market size insights and trends are provided by country, system type, dosage form and distribution channel as referenced above.
The countries covered in the gastroretentive drug delivery systems market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the gastroretentive drug delivery systems market because of the adoption of improved gastroretentive drug delivery solutions and follow-up of advanced treatment methods in healthcare within the region. Asia-Pacific is expected to witness significant growth during the forecast period of 2021 to 2028 due to the surge in spending on research and development activities in emerging countries such as Singapore and Japan.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The gastroretentive drug delivery systems market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for gastroretentive drug delivery systems market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the gastroretentive drug delivery systems market. The data is available for historic period 2010-2019.
Competitive Landscape and Gastroretentive Drug Delivery Systems Market Share Analysis
The gastroretentive drug delivery systems market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related gastroretentive drug delivery systems market.
The major players covered in the gastroretentive drug delivery systems market report are Antares Pharma, Novartis AG, 3M, Sulzer Ltd, Gerresheimer AG, Sanofi, Johnson & Johnson Services, Inc., Bayer AG, GlaxoSmithKline plc, Novosanis, MEDMIX SYSTEMS AG, Merck & Co., Inc., Pfizer Inc., Insulet Corporation, OraSure Technologies, Inc., Enable Injections, West Pharmaceutical Services, Inc., SMC Ltd., ViVO Smart Medical Devices Ltd., Cipla Inc., BD, and F. Hoffmann-La Roche Ltd, among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-
